Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bryant

Showing results (291-300 of 497) with videos related to

Pageof 50
Sort By:
Microbiology (Reading, England)|February 7, 2001
Characterization of the Streptococcus pneumoniae NADH oxidase that is required for infectionJun Yu, Alexander P Bryant, Andrea Marra, et al.
Physiological Genomics|May 22, 2003
Familial hypertrophic cardiomyopathy mutations in troponin I (K183D, G203S, K206Q) enhance filament slidingJan Köhler, Ying Chen, Bernhard Brenner, et al.
The American Journal of Physiology|May 1, 1994
Enhancement of gustatory nerve fibers to NaCl and formation of ion channels by commercial novobiocinA M Feigin, Y Ninomiya, S M Bezrukov, et al.
Microbiology (Reading, England)|July 6, 2000
The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulenceAlison F Chalker, Karen A Ingraham, R Dwayne Lunsford, et al.
Journal of Muscle Research and Cell Motility|November 12, 2020
A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin CTyler R Reinoso, Maicon Landim-Vieira, Yun Shi, et al.
Genomics|December 1, 1992
The CEPH consortium linkage map of human chromosome 2N K Spurr, S Cox, S P Bryant, et al.
Journal of Medicinal Chemistry|February 5, 1993
Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diolD J Kempf, L Codacovi, X C Wang, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1991
Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 proteaseD J Kempf, K C Marsh, D A Paul, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|April 20, 2001
Levitation of cylindrical particles in the sheath of an rf plasmaB M Annaratone, A G Khrapak, A V Ivlev, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Design of orally bioavailable, symmetry-based inhibitors of HIV proteaseD J Kempf, K C Marsh, L C Fino, et al.
Pageof 50

Showing results (291-300 of 497) with videos related to

Sort By:
Pageof 50
Microbiology (Reading, England)|February 7, 2001
Characterization of the Streptococcus pneumoniae NADH oxidase that is required for infectionJun Yu, Alexander P Bryant, Andrea Marra, et al.
Physiological Genomics|May 22, 2003
Familial hypertrophic cardiomyopathy mutations in troponin I (K183D, G203S, K206Q) enhance filament slidingJan Köhler, Ying Chen, Bernhard Brenner, et al.
The American Journal of Physiology|May 1, 1994
Enhancement of gustatory nerve fibers to NaCl and formation of ion channels by commercial novobiocinA M Feigin, Y Ninomiya, S M Bezrukov, et al.
Microbiology (Reading, England)|July 6, 2000
The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulenceAlison F Chalker, Karen A Ingraham, R Dwayne Lunsford, et al.
Journal of Muscle Research and Cell Motility|November 12, 2020
A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin CTyler R Reinoso, Maicon Landim-Vieira, Yun Shi, et al.
Genomics|December 1, 1992
The CEPH consortium linkage map of human chromosome 2N K Spurr, S Cox, S P Bryant, et al.
Journal of Medicinal Chemistry|February 5, 1993
Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diolD J Kempf, L Codacovi, X C Wang, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1991
Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 proteaseD J Kempf, K C Marsh, D A Paul, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|April 20, 2001
Levitation of cylindrical particles in the sheath of an rf plasmaB M Annaratone, A G Khrapak, A V Ivlev, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Design of orally bioavailable, symmetry-based inhibitors of HIV proteaseD J Kempf, K C Marsh, L C Fino, et al.
Pageof 50